ABM 2023
JULY 19-21, 2023
Hosted by the Institute of Fine Arts, NYU,
and the Metropolitan Museum of Art
ABM 2023 brought together a balanced community of experts for a dynamic forum for exchange. The goal of the ABM 2023 meeting was to nurture and grow the community that was established in previous meetings and through recent virtual programming. Key to the meeting was the updating of the website, which serves as a communication hub to identify connections between advanced scientific approaches (e.g., genomic, mass-spectrometry, antibody-based, and other techniques) and open research questions, thereby fostering focused and mutually beneficial collaborations, as well as providing educational resources. An important concern this year is also to secure funding for the continuation of ABM into the future.
PAST MEETINGS
Art Bio Matters began assembling in 2018. You may view the details of our previous meetings here. If you would like to attend ABM meetings in the future, join the ABM community so you can hear the latest news from us.
The virtual ABM 2021 meeting aimed to bring together a balanced community of experts for a dynamic forum for exchange. The goal of the ABM 2021 meeting was to nurture and grow the community that was established in 2018. Key to the meeting was the development of an updated website, which will serve as a communication hub to identify connections between advanced scientific approaches (e.g., DNA, mass-spectrometry, and antibody-based) and open research questions, thereby fostering focused and mutually beneficial collaborations, as well as providing educational resources.
Art Bio Matters 2018 aimed to assemble, for the first time, scientists, curators/art historians, and conservators for a stimulating forum to explore new directions in the study of biological materials in works of art. Through guided and balanced discussions, participants identified connections between advanced DNA, mass-spectrometric, and antibody-based approaches and their own research questions, thereby, facilitating focused and mutually beneficial collaborations.
